Trial reportJournal of neuroengineering and rehabilitation2026
Effect of an exosuit on daily life gait performance in individuals with incomplete spinal cord injury: a randomized controlled trial.
Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05605912 (Efficacy of the Myosuit for Increasing Daily Life Gait Performance in the Home and Community Setting and Gait Capacity in People With Incomplete Spinal Cord Injury), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy of the Myosuit for Increasing Daily Life Gait Performance in the Home and Community Setting and Gait Capacity in People With Incomplete Spinal Cord Injury
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIndividuals with incomplete spinal cord injury (iSCI) often have impaired gait capacity, limiting their gait performance at home and in the community. Lightweight lower extremity exosuits, such as the Myosuit (MyoSwiss AG, Zurich, Switzerland), may offer functional support to improve daily life gait performance. The aim of this randomized controlled trial was to investigate the effect of the Myosuit on daily life gait performance and its usability in individuals with iSCI.
methodsThirty-four individuals with chronic iSCI were randomized (1:1) to either the intervention or control group. The intervention group received a Myosuit program consisting of five gait training sessions, followed by a 6-week home period in which the Myosuit was used as an assistive device. The control group received a conventional program consisting of four gait training sessions, followed by a 6-week home period without the device. Walking time per day was assessed, using an activity monitor, at baseline and during week one, three, and six of the home period. In addition, usability was assessed using the Dutch version of the System Usability Scale (D-SUS) and the Dutch version of the Quebec User Evaluation of Satisfaction with assistive Technology (D-QUEST) questionnaire after the home period.
resultsNo significant group difference in walking time per day during the home period was observed (estimate=9 min, robust standard error=8, p=0.23). The average D-SUS score was 56 ± 21 and the D-QUEST score was 3.4 ± 0.5.
conclusionMyosuit use at home and in the community did not lead to improved daily life gait performance in individuals with iSCI. Usability was marginal, suggesting that further improvements of exosuit design and functionality are necessary to enhance its effectiveness and user acceptance in real-world settings. Trial registration Clinicaltrials.gov NCT05605912. Registered on October 19, 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.